287 related articles for article (PubMed ID: 19056138)
1. Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions.
Aguiar-Souto P; Ferrante G; Del Furia F; Barlis P; Khurana R; Di Mario C
Int J Cardiol; 2010 Feb; 139(1):68-74. PubMed ID: 19056138
[TBL] [Abstract][Full Text] [Related]
2. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
Worasuwannarak S; Pornratanarangsi S
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
[TBL] [Abstract][Full Text] [Related]
3. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.
Marenzi G; Lauri G; Assanelli E; Campodonico J; De Metrio M; Marana I; Grazi M; Veglia F; Bartorelli AL
J Am Coll Cardiol; 2004 Nov; 44(9):1780-5. PubMed ID: 15519007
[TBL] [Abstract][Full Text] [Related]
4. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.
Kandula P; Shah R; Singh N; Markwell SJ; Bhensdadia N; Navaneethan SD
Nephrology (Carlton); 2010 Mar; 15(2):165-70. PubMed ID: 20470274
[TBL] [Abstract][Full Text] [Related]
5. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.
Iakovou I; Dangas G; Mehran R; Lansky AJ; Ashby DT; Fahy M; Mintz GS; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
J Invasive Cardiol; 2003 Jan; 15(1):18-22. PubMed ID: 12499523
[TBL] [Abstract][Full Text] [Related]
6. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
[TBL] [Abstract][Full Text] [Related]
7. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system.
Harjai KJ; Raizada A; Shenoy C; Sattur S; Orshaw P; Yaeger K; Boura J; Aboufares A; Sporn D; Stapleton D
Am J Cardiol; 2008 Mar; 101(6):812-9. PubMed ID: 18328846
[TBL] [Abstract][Full Text] [Related]
8. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome.
Senoo T; Motohiro M; Kamihata H; Yamamoto S; Isono T; Manabe K; Sakuma T; Yoshida S; Sutani Y; Iwasaka T
Am J Cardiol; 2010 Mar; 105(5):624-8. PubMed ID: 20185007
[TBL] [Abstract][Full Text] [Related]
9. Serious renal dysfunction after percutaneous coronary interventions can be predicted.
Brown JR; DeVries JT; Piper WD; Robb JF; Hearne MJ; Ver Lee PM; Kellet MA; Watkins MW; Ryan TJ; Silver MT; Ross CS; MacKenzie TA; O'Connor GT; Malenka DJ;
Am Heart J; 2008 Feb; 155(2):260-6. PubMed ID: 18215595
[TBL] [Abstract][Full Text] [Related]
10. Contrast-induced nephrotoxicity in renal allograft recipients.
Ahuja TS; Niaz N; Agraharkar M
Clin Nephrol; 2000 Jul; 54(1):11-4. PubMed ID: 10939751
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
Toso A; Maioli M; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Manzone C; Amato M; Bellandi F
Am J Cardiol; 2010 Feb; 105(3):288-92. PubMed ID: 20102936
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
[TBL] [Abstract][Full Text] [Related]
13. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease.
Toprak O; Cirit M; Esi E; Postaci N; Yesil M; Bayata S
Catheter Cardiovasc Interv; 2006 Feb; 67(2):227-35. PubMed ID: 16400673
[TBL] [Abstract][Full Text] [Related]
14. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
[TBL] [Abstract][Full Text] [Related]
15. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
[TBL] [Abstract][Full Text] [Related]
16. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
[TBL] [Abstract][Full Text] [Related]
17. Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention.
Conen D; Buerkle G; Perruchoud AP; Buettner HJ; Mueller C
Int J Cardiol; 2006 Jun; 110(2):237-41. PubMed ID: 16298441
[TBL] [Abstract][Full Text] [Related]
18. Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention.
Lin YS; Fang HY; Hussein H; Fang CY; Chen YL; Hsueh SK; Cheng CI; Yang CH; Chen CJ; Hang CL; Yip HK; Wu CJ
EuroIntervention; 2014 Feb; 9(10):1173-80. PubMed ID: 24561734
[TBL] [Abstract][Full Text] [Related]
19. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
Maioli M; Toso A; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Bellandi F
J Am Coll Cardiol; 2008 Aug; 52(8):599-604. PubMed ID: 18702961
[TBL] [Abstract][Full Text] [Related]
20. Impact of acute renal failure following percutaneous coronary intervention on long-term mortality.
Roghi A; Savonitto S; Cavallini C; Arraiz G; Angoli L; Castriota F; Bernardi G; Sansa M; De Servi S; Pitscheider W; Danzi GB; Reimers B; Klugmann S; Zaninotto M; Ardissino D;
J Cardiovasc Med (Hagerstown); 2008 Apr; 9(4):375-81. PubMed ID: 18334892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
